Acute Myeloid Leukemia: Evaluating Novel Formulations and Emerging Agents
2 Views
administrator
07/04/23
Earn CME for related activities: https://www.naccme.com/mcln
This webcast features presentations on the limitations of current AML treatments in terms of survival, tolerability, quality of life, hospitalizations, and utilization, and examines the clinical and pharmacoeconomic profiles of novel chemotherapeutic formulations and targeted agents.
© 2017 North American Center for Continuing Medical Education, LLC, an HMP Communications Holdings Company.
-
Category
Show more
Facebook Comments
No comments found